Tech Company Financing Transactions
Ikonisys Funding Round
Ikonisys, based in New Haven, secured $10 million from New Science Ventures and Trevi Health Ventures.
Transaction Overview
Company Name
Announced On
3/8/2006
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series D
Investors
Trevi Health Ventures (Andrew Fink)
Proceeds Purpose
Ikonisys expects to rapidly advance its prenatal diagnostics program to FDA submission and further develop its oncology program.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
5 Science Park
New Haven, CT 06511
USA
New Haven, CT 06511
USA
Phone
Website
Email Address
Overview
Ikonisys pioneering technology and laboratory testing offers cancer diagnosis based on rare cancer cell detection.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Michael Kilpatrick
VP - Operations
William Kochiss
Browse more venture capital transactions:
Prev: 3/8/2006: Neuromed Pharmaceuticals venture capital transaction
Next: 3/8/2006: Obopay venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records on this site come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs